Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, has captured investor attention with its diverse portfolio of preparedness and response solutions for..
Investors with an eye on the healthcare sector may find Myriad Genetics, Inc. (NASDAQ: MYGN) worth a deeper look. The company, based in Salt Lake City,..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands out in the medical devices industry with a promising potential upside of 23.96%, making it a noteworthy candidate for..
Castle Biosciences, Inc. (NASDAQ: CSTL) is capturing investor attention with a compelling 47% potential upside based on its average target price. As a key player in..
Semler Scientific, Inc. (NASDAQ: SMLR), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a striking potential..
Owens & Minor, Inc. (NYSE: OMI) stands as a significant player in the healthcare sector, specifically within medical distribution. With a market capitalization of $406.3 million,..
Investors looking to explore opportunities within the healthcare sector should pay close attention to SIGA Technologies Inc. (NASDAQ: SIGA). This commercial-stage pharmaceutical company, headquartered in New..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing attention in the biotechnology sector, not only for its innovative approach to tackling cancer but also for the impressive..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is capturing attention with its impressive projected upside of nearly 196.70%. Specializing in developing treatments for cancer,..
Oculis Holding AG (OCS), a Switzerland-based biopharmaceutical company, has caught the attention of investors with its promising portfolio in ophthalmic drug development. Operating within the healthcare..
Investors with an eye on the healthcare sector might find AxoGen, Inc. (NASDAQ: AXGN) an intriguing candidate for their portfolios. Specializing in medical devices, this Florida-based..
Cel-Sci Corporation (NYSE American: CVM) has caught the attention of investors with its staggering potential upside of 1,902.39%, as suggested by recent analyst ratings. This clinical-stage..
Theravance Biopharma, Inc. (NASDAQ: TBPH) is capturing investor interest with its notable potential upside of 41.44%, a compelling figure for those looking to delve into the..
Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA), a prominent player in the biotechnology sector, is drawing considerable attention from investors due to its innovative approach to cell..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is making waves in the biotechnology sector with its focus on developing breakthrough treatments for severe autoimmune and inflammatory diseases. With..
Syndax Pharmaceuticals, Inc. (SNDX) has recently caught the attention of investors with a compelling potential upside of 156.76%, as indicated by its average target price of..
For investors eyeing opportunities in the healthcare sector, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents an intriguing proposition. Specializing in the development and commercialization of pain management..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is garnering attention from investors with its promising focus on rare respiratory diseases. With a market capitalization of..
For investors eyeing opportunities within the healthcare sector, Cross Country Healthcare, Inc. (NASDAQ: CCRN) presents a compelling case with its significant potential upside. Despite the current..
Precigen, Inc. (NASDAQ: PGEN), a trailblazer in the biopharmaceutical sector, has captured investor attention with its advanced gene and cell therapy platforms targeting critical areas such..
